SPONSOR
Regor Pharmaceuticals Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Breast CancerOvarian CancerEndometrial CancerPIK3CA MutationHER2- Negative Breast CancerAdvanced Breast CancerUnresectable Solid TumorHormone Receptor Positive TumorCervical Cancer
Clinical Trials by Regor Pharmaceuticals Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology